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20EOXI Vigo, University of Vigo, Calle Zaragoza, Vigo, 36203 Pontevedra, Spain
Correspondence should be addressed to Birgitta Weltermann; birgitta.weltermann@uk-essen.de
Received 10 June 2016; Accepted 28 July 2016
Academic Editor: Fabio Firenzuoli
Copyright © 2016 AnikaThielmann et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2016, Article ID 6949202, 9 pages
http://dx.doi.org/10.1155/2016/6949202
2 Evidence-Based Complementary and Alternative Medicine
Background.Patients use self-care to relieve symptoms of common colds, yet little is known about the prevalence and patterns across
Europe. Methods/Design. In a cross-sectional study 27 primary care practices from 14 countries distributed 120 questionnaires
to consecutive patients (≥18 years, any reason for consultation). A 27-item questionnaire asked for patients’ self-care for their
last common cold. Results. 3,074 patients from 27 European sites participated. Their mean age was 46.7 years, and 62.5% were
females. 99% of the participants used ≥1 self-care practice. In total, 527 different practices were reported; the age-standardized
mean was 11.5 (±SD 6.0) per participant. The most frequent self-care categories were foodstuffs (95%), extras at home (81%),
preparations for intestinal absorption (81%), and intranasal applications (53%). Patterns were similar across all sites, while the
number of practices varied between and within countries. The most frequent single practices were water (43%), honey (42%),
paracetamol (38%), oranges/orange juice (38%), and staying in bed (38%). Participants used 9 times more nonpharmaceutical
items than pharmaceutical items.The majority (69%) combined self-care with and without proof of evidence, while ≤1% used only
evidence-based items. Discussion. This first cross-national study on self-care for common colds showed a similar pattern across
sites but quantitative differences.
1. Introduction
Common colds are the most frequently encountered human
diseases worldwide [1]. Common cold is a conventional term
used for mild upper respiratory illnesses, which comprises
a heterogeneous group of self-limited diseases caused by
numerous viruses. The frequency is age-specific with fewer
episodes in adults than in younger children [2, 3] and a
seasonal variation with more episodes in winter and fall
[1]. Beyond impairing the quality of life [4], common colds
have a tremendous economic burden on societies due to
work absenteeism (70million workdays annually due to non-
influenza-related viral respiratory tract infections in the US,
which corresponds to US$8 billion indirect costs) [5–7]. If
consulted, general practitioners are asked to provide support-
ive advice, symptomatic treatment, and reassurance [8].
Studies on self-care have shown that common colds are
the most frequent cause for self-care [9–12]. This is reason-
able, as common colds have a self-limited course and resolve
without treatment. Unsystematic practice observations and
the few studies available indicate that patients use amixture of
evidence-based and non-evidence-based self-care practices
including self-medication and traditional home remedies
to reduce symptoms and improve subjective well-being
(e.g., [9, 12–14]). Nevertheless, only few self-care practices
have been studied and proven to be effective in relieving
symptoms of common colds in adults, such as nonsteroidal
anti-inflammatory agents [15], antihistamines [16], and oral
antihistamine-decongestant-analgesic combinations [17].
Although self-care for minor illnesses is recognized as
an important component of primary health care, little is
known about the prevalence andpatterns of self-care for com-
mon colds across Europe. Drawing on data from 27 primary
care sites of 14 countries, the cross-sectional COCO study
describes the variety and pattern of reported self-care prac-
tices.
2. Methods and Materials
2.1. Study Design. This multicenter, cross-sectional survey
was performed at 27 primary sites in 14 European countries.
Details of the study design have been published earlier [18].
Briefly, the cross-national survey was designed and con-
ducted by the Working Group on Self-Care of the European
General Practice Research Network (EGPRN). The data
collection was completed in April, 2014.
2.2. Study Instrument and Data Collection. A 27-item self-
administered patient questionnaire provided 94 self-care
practices and free text options in 11 categories: over-the-
counter medication, specific foods or drinks, herbal teas,
alcoholic drinks, special self-prepared recipes, pastilles or
drops, something for the nose, inhalation, throat gargle/spray,
items applied externally, and extras at home. In addition,
the following patient characteristics were requested: age,
gender, health insurance status, number of school years, pills
taken daily, and expenditures for the last common cold.
To assure random samples at all sites, the questionnaires
were distributed to consecutive patients independent of their
reason for physician consultation. Inclusion criteria were the
following: being ≥18 years, being able to understand the
questionnaire, or being in attendance of someone providing
assistance.
2.3. Patient Involvement. Primary care physicians who devel-
oped and conducted the study had a dual role as professionals
and as patients who experienced common colds themselves.
Results of the COCO study will be disseminated in form of
patient information materials.
2.4. Sample Size Calculation. To obtain a representative sam-
ple for a practice of up to 10,000 patients, a total of 94
patients had to be studied (CI 95%; SE 0.05; accuracy 0.1).
This estimate was based on the assumption that the sample
of patients surveyed is random for the respective practice.
To account for nonresponders, oversampling by 25% was
planned, which led to a sample size of 117.5 (94 + 23.5
patients), rounded to 120 patients per primary care setting.
This sample size also yielded representative results for items
with a prevalence in the range of 40% to 60% in the general
population. For details see Weltermann et al. [18].
2.5. Statistical Analysis. Self-care items were classified by 2
researchers in terms of their mode of application: “intestinal
absorption,” “intranasal application,” “local oral effects,”
“inhalation,” “topical use in throat,” “external use,” “food-
stuffs,” and “extras at home.” In a subclassification, single
items were further subclassified using the ATC (WHO
Anatomical Therapeutic Chemical) classification system for
pharmacological substances and—if not listed—plausible
groups and subcategories. Items were listed individually if
they had a utilization rate of at least 1% (𝑛 ≥ 27) prior to age
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standardization; otherwise, they were summarized as “other”
within each mode.
Descriptive analyses of all self-care practices were per-
formed for the total study population and stratified by coun-
try. To account for differences in age distributions between
European countries and practice samples, results were age-
standardized using the 2013 European Standard Population
[19]. Data were analyzed on the basis of five aspects:
(1) “Number of self-care practices used”: (a) mean item
use; (b) the average number of items per 100 par-
ticipants stratified by country; and (c) prevalence of
using any self-care were considered.
(2) “Mode of application”: (a) distribution of all single
items reported per mode of application; (b) % of
participants using at least one item per mode; and
(c) mean item use per mode (subclassification) were
considered.
(3) “Single items used” (subclassification): (a) the most
frequently used single items; (b) the sum of the five
most frequently used items per country; (c) fre-
quently used items (≥5% utilization rate); and (d)
rarely used items (1% to 5% utilization rate) were con-
sidered (selected itemsused by<1%of the participants
were reported).
(4) “Evidence-based self-care”: based on 14 Cochrane
reviews [15–17, 20–30] and one other review [31],
items were grouped according to their evidence of
effectiveness for the treatment of common colds in
adults. Prevalence of the use of these evidence-based
products was expressed as a ratio (non-evidence-
based/evidence-based measures). In addition, all
items with an ATC code and “antibiotics” were
grouped as pharmaceutical products.
(5) “Analysis by the countries’ purchasing power stan-
dard (PPS)”: based on the PPS, countries were clas-
sified into three groups. The PPS is an artificial value
which is based on each nation’s Gross Domestic
Product and eliminates price level differences among
countries [32]: PPS I included Austria, Sweden, Ger-
many, and Finland; PPS II included France, Israel,
Italy, Spain, and Slovenia; PPS III included Poland,
Turkey, and Macedonia. Analyses included (a) the
mean item use, (b) the use of evidence-based self-care
(at least 1, mean), (c) the use of pharmaceutical prod-
ucts (at least 1, mean), and (d) the mean expenditure
in the 3 PPS groups.
The analysis included all returned questionnaires. Statistical
analyseswere performedusing IBM SPSS Statistics, version
20 and SAS version 9.4 statistical package (SAS Institute, Inc.,
Cary, NC, USA).
3. Results
3.1. Characteristics of the Participants. A total of 27 sites from
14 European countries participated in the survey. 3,074 ques-
tionnaires were returned. After excluding data from sites
Table 1: Characteristics of participants (𝑛 = 2,724).
𝑛 %
Gender, female (𝑛 = 2,654) 1,659 62.5%
Insurance status, public (𝑛 = 2,587) 2,494 96.4
Nonsmoker (𝑛 = 2,638) 2,052 77.8
Patients with ≥1 self-reported chronic
condition 1,086 39.9
Hypertension 608 56
Chronic pain/arthritis 257 23.7
Heart disease 242 22.3
Diabetes 221 20.3
Asthma/chronic bronchitis 197 18.1
Depression 143 13.2
Chronic kidney disease 55 5.1
Age, mean ± SD (𝑛 = 2,644) 46.7 ± 16.8
Years of formal education, mean ± SD (𝑛 =
2,557) 12.8 ± 4.49
Number of tablets used daily, mean ± SD (𝑛
= 2,318) 2.0 ± 2.7
Patients with ≥1 tablet daily (𝑛 = 1,467)
ASA/aspirin 314 21.4
Oral contraceptive 165 11.2
Anticoagulants 80 5.5
Participating countries (𝑛 = 2,724)
Austria∘ 110 4
Finland# 107 3.9
France, 3 sites+# 325 11.9
Germany, 3 sites+∘# 385 14.1
Israel+ 123 4.5
Italy, 2 sites#∘ 161 5.9
Macedonia∘ 364 13.4
Poland, 2 sites+ 241 8.8
Slovenia∘ 119 4.4
Spain+ 86 3.2
Sweden+ 98 3.6
Turkey, 5 sites∘+ 605 22.2
∘Mixed (urban/rural); +urban; #rural.
with different sampling strategies (patient-physician inter-
views in Romania; use of an older questionnaire version
in Bosnia-Herzegovina; and incomplete questionnaire dis-
tribution in 3 of 6 German sites), the total study popula-
tion consisted of 2,724 participants from 22 sites and 12
countries. See Table 1 for details of the participants and
Additional File 1 in Supplementary Material available online
at http://dx.doi.org/10.1155/2016/6949202 for characteristics
per data sampling site/primary care practice.
62.5% of the participants were female and the mean age
was 46.7 years. On average, participants had 12.8 years of
formal education (including higher education). 41% of the
participants self-reported at least one chronic condition. On
average, patients were taking 2 tablets daily and 3.1 (±SD 2.9)
tablets in the subgroup of those with at least one daily tablet.
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Figure 1: Pattern of self-care by mode of application stratified by country: percentage (%) of using at least 1 item within each mode (weighted
by age).
3.2. Number of Practices Used. In total, 527 items were
reported. Of these, 483 items were reported as free text
options.The age-standardized totalmean itemutilizationwas
11.5 (±SD 6.0, range: 0–53). In total, 99% of participants used
any kind of self-care practices. Comparative analyses for open
and closed answers showedmean item utilization of 1.6 (±SD
1.0) and 11.0 (±SD 6.6, range: 0–53), respectively.
Comparisons between countries showed a variation by
factor 6.4 in the spectrum size for the stated number of
different items per 100 participants (35/100 in Macedonia
compared to 224/100 in Turkey). We largely abstained from
comparisons between countries, because within-country
comparisons showed differences of up to 38% in modes of
applications and 4.9% in item utilization (see Additional File
1 in Supplementary Material).
3.3. Mode of Application Level. Of all 527 items used, “food-
stuffs” was reported most frequently (52%). With 276 items,
this is also the mode with the largest number of reported
items.Much fewer itemswere reported for “intestinal absorp-
tion” (9%, 48 items), “inhalation” (8%, 42 items), “extras
at home” (7%, 37 items), “intranasal application” (7%, 36
items), “local oral effects” (6%, 32 items), and “topical use in
throat” and “external use” (both 5%, 28 items). Details on the
percentages for the utilization of at least one item per mode
of application and the mean item utilization for each mode
stratified by country are displayed in Figures 1 and 2.
3.4. Single Items Used
3.4.1. Self-Care Practices Used by at Least 1% of Participants.
After grouping single items based on (a) content (related
practices) and (b) utilization rate (≥1%), the spectrum of
self-care comprised 97 items. After age-standardization, the
most frequently reported single items were water (43%),
honey (42%), paracetamol (38%), oranges/orange juice
(38%), staying in bed (38%), bath/shower (35%), rest at home
(34%), lemons/lemon juice (31%), and chicken soup (30%).
Water and/or honey were among the three most frequently
used items in 9 countries, oranges/orange juice, staying in
bed, and/or pain medication in 5 countries, and rest at home
and/or chicken soup in 4 countries. In the total sample, ≥2
of the five most frequent items (water, honey, paracetamol,
oranges/orange juice, and staying in bed) were used by 63%
of the participants, and 34% used at least 3 of these items.
The five most frequently used self-care practices of each
country added up to 19 different self-care practices across all
countries: bath/shower, rest at home, staying in bed, chicken
soup, lemons/lemon juice, oranges/orange juice, mandarins,
other fruits incl. “more fruit,” lime blossom tea, mixed
herbal tea, honey, hot milk with honey, water, ibuprofen,
paracetamol, vitamin C, nasal decongestants, saline for nose,
and pastilles for cough.
An overview on the frequently used self-care practices,
that is, items with a utilization rate of at least 5%, is provided
in Table 2; items rarely used (1% to 5%) are provided in
Table 3.When taking all items into account, fluids of any type
were used by 92% of participants, including any tea by 74%
and any alcohol-containing liquids by 12%. Fruit and/or juices
were used by 70%of participants and vegetables by 24%. Soup
was consumed by 31%. With regard to “extras at home,” 56%
of participants reported preferring to “stay in bed,” “sleep,” or
“rest at home” and 57% used something related to “warmth.”
For “intestinal absorption” it is noteworthy that 60% of
participants used at least one pain medication. Moreover,
although the questionnaire item vitamin C was chosen by
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Figure 2: Pattern of self-care by mode of application stratified by country: mean utilization of items within each mode (weighted by age).
28%, when also considering fruit-based vitamin C (citrus
fruits and juices) it is 68%. At least one nose drop/spray was
reported by 36% of participants, at least one flavored lozenge
by 33%, at least one gargle by 17%, and at least one rub by 10%.
3.4.2. Self-Care Practices Used by FewerThan 1% of the Partic-
ipants. Besides the above-reported practices used by at least
1% and 5% of the participants, it is noteworthy to mention
some of the 437 practices that are used by less than 1%, some
of which can certainly be described as curiosa. Examples are
as follows: “topical use in throat”: oil pulling/swishing (𝑛 = 1),
sulfur (𝑛 = 1), vinegar (and sage) (𝑛 = 6), soda/baking
powder (𝑛 = 5), and salt and soda (𝑛 = 4); “external use”:
compresses with curd cheese or horseradish (each 𝑛 = 1), rub
with olive oil (𝑛 = 7), and fire cupping (𝑛 = 13); “inhalation”:
cold mist (𝑛 = 2); “extras at home”: hot light (𝑛 = 4), physical
activity (𝑛 = 10), and foot bath (𝑛 = 5); and “foodstuffs”:
pickle juice (𝑛 = 3), amber with alcohol (𝑛 = 15), Coca Cola
(𝑛 = 3), orchid hot drink (𝑛 = 2), lemonade (𝑛 = 1), various
mixtures for syrups and syrup-like solid foodstuffs based on
honey or sugar in combination with, for example, lemon or
ginger (𝑛 = 21), tripe soup (𝑛 = 4), or tea with Inonotus
obliquus (a mushroom), and a shot of wheat (𝑛 = 1).
3.5. Evidence-Based Products Proven to Be Somewhat Effective.
In total, 21 self-care items were grouped as evidence-based.
See Table 4 for an overview. The mean of evidence-based
products was 1.1 items (±SD 0.97) and ranged between 0
and 5 items. Of the 2,691 participants using self-care, solely
evidence-based self-care was used by 0.3% of participants,
solely non-evidence-based self-care was used by 31.2%, and
a combination of both was used by 68.5%. In participants
who combine both, participants used 8.0 times more non-
evidence-based items than evidence-based items.
An additional 35 items were grouped as non-evidence-
based pharmacological products which were used by 4.6%
(𝑛 = 124) of the participants. Any pharmaceutical products—
irrespective of their evidence-based status—were used by
62% of the participants. Participants who combined phar-
maceutical and nonpharmaceutical products used 9.0 times
more nonpharmaceutical products than pharmaceutical pro-
ducts.
3.6. Analysis by the Countries’ Purchasing Power Standard.
The number of items differed between PPS groups: with a
mean of 12.4 (±SD 7.2) it was highest in the lowest PPS
group (III) and equal—although lower—in PPS II (10.6,
±SD 5.8) and PPS III (10.5, ±SD 6.2). Conversely, the use
of evidence-based products decreased with increasing PPS
(PPS I: 77%, PPS II: 71%, and PPS III: 58%), as did the
use of pharmaceutical products (PPS I: 69%, PPS II: 61%,
and PPS III: 54%). The mean items used for evidence-based
products and pharmaceutical products differed marginally
(with increasing PPS: evidence-based products: 1.2, 1.1, and
0.9; pharmaceutical products: 1.0, 0.8, and 0.8).
An estimate of the expenditure per common cold was
reported by 86% (𝑛 = 1,284) of the participants: 10.8 Euros
were spent on average (±SD 13.5; range: 0–250). The amount
differed by PPS: PPS I: 13.8, ±SD 16.8; PPS II: 10.4, ±SD 12.1;
and PPS III: 8.1, ±SD 9.3.
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Table 2: Frequently used (≥5%) self-care practices on item level (𝑛
= 2,724), weighted by age∗.
𝑛 %
Foodstuffs (95.2% ≥ 1 item; mean use: 5.2)
Tea
Fruit
Lemon + honey 495 18.0
Cranberry 181 6.6
Herbal
Peppermint/mint 474 17.9
Chamomile 477 17.3
Sage 442 16.8
Lime blossom 371 14.0
Ginger 349 13.4
Thyme 208 7.9
Cinnamon 202 7.9
Mixed 468 17.7
Black/green 299 11.0
Other 161 6.3
Fruits
Oranges/orange juice 1,029 38.1
Lemons/lemon juice 837 31.1
Mandarins 684 25.2
Grapefruits/grapefruit juice 185 6.7
Other fruits incl. “more fruit” 798 29.4
Vegetables
Garlic 423 15.2
Other vegetables incl. “more vegetables” 396 14.0
Honey
Honey 1,138 41.9
Hot milk + honey 531 19.3
Alcohol
Tea with rum 137 5.0
Water 1,168 42.8
Chicken soup 811 29.8
Intestinal absorption (80.8% ≥ 1 item; mean use: 1.9)
Pain medication
Paracetamol 1,019 38.2
Ibuprofen 417 15.7
ASA/aspirin 384 13.7
“Pain medication” (unspecific) 319 12.0
Cough medicine
Syrup for cough 516 18.5
Pastilles for cough 419 15.4
Drops for cough 228 8.2
Vitamin C 758 28.2
“Pills for cold” (unspecific) 528 19.9
“Homeopathics” (unspecific) 183 6.9
Table 2: Continued.
𝑛 %
Extras at home (80.5% ≥ 1 item; mean use: 2.1)
Staying in bed 1,020 38.1
Bath/shower 930 35.3
Rest at home 909 33.7
Warm clothes 735 27.2
Open windows 585 22.0
Warm covers 495 18.6
Take a day/days off 370 14.4
Hot water bottle 303 11.3
Pray for recovery 224 8.5
Intranasal application (53.1% ≥ 1 item; mean use: 0.7)
Decongestants 703 26.5
Saline for nose 479 18.1
Nose drops/spray (unspecific) 287 10.8
Nasal washings 216 8.2
Inhalation (36% ≥ 1 item; mean use: 0.6)
Peppermint/menthol 399 14.6
Saline 182 7.0
Chamomile 142 5.1
Pot with steaming water (unspecific) 390 14.3
Local oral effects (35.3% ≥ 1 item; mean use: 0.5)
Lozenges
Lemon 296 10.7
Eucalyptus 269 10.0
Sage 260 9.6
Peppermint 241 9.1
Topical use in throat (33.2% ≥ 1 item; mean use: 0.4)
Gargle
Saline 283 10.2
Sage 187 6.8
Throat spray 401 15.2
External use (13.6% ≥ 1 item; mean use: 0.2)
Rub with essential oils 172 6.5
∗European Standard Population 2013.
4. Discussion
This is the first study on self-care for common cold with data
from several European countries. According to the COCO
data, European primary care patients can consistently be
considered as high users of self-care for common colds.
Prevalence of application modes showed similar patterns
across countries, while the number of items on country
level varied markedly: the modes “foodstuffs,” “intestinal
absorption,” and “extras at home” were the most frequently
usedmodes in 10 countries, with “foodstuffs” representing the
most frequently used one across all countries. Of the large
spectrumof 527 practices reported, 19 self-care practices rank
among the top five across countries.
Evidence-Based Complementary and Alternative Medicine 7
Table 3: Rarely used (1% to <5%) self-care practices on item level (𝑛
= 2,724), weighted by age∗.
𝑛 %
Foodstuffs
Tea
Fruit
Elderberry 124 4.7
Raspberry 109 3.9
Apple peel 62 2.4
Other/unspecific 555 2.3
Herbal
Marshmallow root 129 4.8
Echinacea propolis 104 4.0
Eucalyptus 91 3.3
Pine syrup 73 2.7
St. John’s wort 70 2.6
Verbena 37 1.4
Other/unspecific 73 2.7
Alcohol
Mulled wine 104 3.8
Alcohol added to other liquids 39 1.4
Beer/wine 36 1.2
Onion cough syrup 112 4.1
Milk with butter 106 3.9
Onion juice with honey 100 3.8
Food with marjoram 86 2.9
Other solid food 66 2.5
Soup: other/unspecific 49 1.9
Other liquids 45 1.7
Intestinal absorption
Calcium 126 4.3
Zinc 64 2.4
Plantago cough syrup 65 2.3
Umckaloabo 35 1.4
Extras at home
Electric warming blanket 55 2.1
Inhalation
Eucalyptus (oil) 129 4.8
Essential oil (unspecific) 117 4.5
Camphor (oil) 27 1.0
Local oral effects
Herbal lozenges (unspecific) 127 4.8
Cinnamon lozenges 37 1.4
Oral antiseptics 35 1.4
Topical use in throat
Gargle with chamomile 71 2.5
Anti-infectives 44 1.6
External use
Chest rub with alcohol 93 3.5
Calf compress 61 2.3
Cupping 54 2.0
∗European Standard Population 2013.
4.1. Strengths and Limitations of the Study. This is the first
study to analyze prevalence and patterns of self-care for
common colds on a larger European scale. Contrary to
previous studies it used a rather explorative approach and did
not restrict self-care to the use of OTC or home remedies.
Table 4: Use of evidence-based self-care (𝑛 = 2,724), weighted by
age∗.
𝑛 %
Paracetamol (N02BE01)∗∗ 1008 37.8
Nasal decongestant, unspecific 687 25.9
Ibuprofen (M01AE14) 417 15.8
Acetylsalicylic acid (ASA) (N02BA01) 384 13.7
Pain medication, unspecific 319 12
Pelargonium sidoides (umckaloabo) 35 1.4
Paracetamol in combinations (N02BE51) 16 0.6
Mefenamic acid (M01AG01) 4 0.2
Metamizole (N02BB02) 6 0.2
Xylometazoline (R01AA07) 4 0.2
Naphazoline (R01AA08 ) 2 0.1
Pseudoephedrine (R01BA02) 2 0.1
Diclofenac (M01AB05) 1 0.0
Naproxen (M01AE02) 1 0.0
Other antihistamines for systemic use (R06AX) 1 0.0
Loratadine (R06AX13) 1 0.0
Fexofenadine (R06AX26) 1 0.0
Ephedrine (R01AA03) 1 0.0
Oxymetazoline (R01AA05) 1 0.0
Sympathomimetics, combinations excl. corticosteroids
(R01AB) 1 0.0
Pseudoephedrine, combinations (R01BA52) 1 0.0
∗European Standard Population 2013; ∗∗in parenthesis: ATC code if avail-
able.
Age standardization was used to account for differences
in ages between sites and countries. This study was not
without limitations. Firstly, due to the sampling strategy,
results are representative only for primary care practices/sites.
Therefore, we largely abstained from country comparisons.
Secondly, we did not ask for the participants’ reason for
using certain self-care practices (e.g., reduction of duration,
symptomatic relief, and targeted symptoms) and how they
appraise the evidence. Thirdly, we did not ask whether
patients’ current physician consultation was due to an acute
cold. Fourthly, coding unspecific answers might have led to
an underrepresentation of pharmaceutical products. Women
were overrepresented in our sample, likely due to generally
more physician visits by women and the feminization of the
elderly population. In addition, participantswithmore school
years are overrepresented as compared to the EU population.
4.2. ComparisonwithOther Studies. Theobserved prevalence
of self-care utilization close to 100% is higher than reported
in other studies. For instance, the prevalence was only 84% in
the British general population [14] and 69% in Estonian phar-
macy customers [33]. In addition, we showed that patients
engage in a variety of self-care practices, as the spectrum of
reported self-care items among the sites in the 12 countries
comprised more than 500 items, on average 12 items per
person. Few studies are available for comparison. Irrespective
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of the health issue, German primary care patients (𝑛 = 480)
used on average 22 home remedies [9]. Specifically regarding
colds, the Estonian survey showed average utilization of 4.1
medicinal plants alone [33], and in an American survey
among parents (𝑛 = 153) with a focus on children 3.8 (Euro-
pean Americans) and 3.2 (African Americans) items were
reported on average [34].
Turning to self-medication, 62% used pharmaceutical
products, which is higher than the 52% reported in the British
survey (𝑛 = 4,327) [13] and the 44% reported in Estonian
pharmacy customers (𝑛 = 300) who used a combination of
herbal products/medicinal plants and self-medication [33].
Based on a review of the literature, we identified 21 self-care
items in the COCO data that are discussed as possibly being
beneficial for cold symptoms in adults; the majority of items
lack an assessment for effectiveness or were shown to be inef-
fective. Of the fivemost frequently reported items (utilization
of about 40% each), that is, “water,” “honey,” “paracetamol,”
“oranges/orange juice,” and “staying in bed,” only paraceta-
mol is evidence-based. Overall with two thirds, the major-
ity of participants engaged in self-care that includes both
evidence-based items and items without proof of evidence.
The most frequently reported evidence-based items were
nasal decongestants followed by the various painmedications
(NSAIDs and paracetamol). Examples for non-evidence-
based self-care are that one third of respondents still use
vitamin C and another 15% use garlic, which can both be
considered treatment myths [22, 26]. Similarly, the use of
inhalations by about one third is not supported by evidence
[28]; the same applies for chest rubs [31]. With 12%, also the
non-evidence-based use of alcohol—either drunk alone or
added to other liquids—is surprisingly high.
5. Conclusions
This study adds to the knowledge on the prevalence and pat-
terns of cold self-care and clearly demonstrates that self-
care for cold is frequent, even among those with relatively
low utilization. As such, the data are representative on the
level of the participating primary care practices. Overall,
the documented commitment for self-care is in line with
European wide attempts to promote self-care for minor ill-
nesses in order to reduce health care system expenditures and
the workload of general practitioners. Nevertheless, given
the poor evidence base, the high engagement in self-care
highlights the need for patient-directed information. Such
information should address the evidence base and safety of
self-care practices. Furthermore, studies that evaluate the
effectiveness of the frequently used, poorly studied items for
common colds are needed.
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